GLAXO
NIFTY500
Glaxosmithkline Pharmaceuticals Ltd.
Pharma · NSE
₹2,476.90
1Y-11.7%
52-week range
₹2,218 – ₹3,516
From 52w high
-29.6%
RSI (14)
59.1
vs SMA 50 / 200
↑ 50 · ↓ 200
PE
40.5
Forward PE
35.5
ROE
—
Profit margin
26.9%
D/E
2.09
Dividend yield
1.70%
Quality score
51/100
Revenue growth
9.7%
Earnings growth
28.6%
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.